Selecta Biosciences, Inc.
SELB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $38,913 | $0 | $110,777 | $85,077 |
| % Growth | – | -100% | 30.2% | – |
| Cost of Goods Sold | $0 | $0 | $72,377 | $68,736 |
| Gross Profit | $0 | $0 | $38,400 | $16,341 |
| % Margin | 0% | – | 34.7% | 19.2% |
| R&D Expenses | $45,105 | $71,839 | $72,377 | $68,736 |
| G&A Expenses | $30,126 | $40,581 | $23,862 | $20,938 |
| SG&A Expenses | $30,126 | $40,581 | $23,862 | $20,938 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $7,579 | $0 | $330 | $15 |
| Operating Expenses | $82,810 | $112,420 | $96,239 | $89,674 |
| Operating Income | $0 | -$86,416 | $14,538 | -$4,597 |
| % Margin | 0% | – | 13.1% | -5.4% |
| Other Income/Exp. Net | $0 | -$152,294 | $20,232 | -$5,124 |
| Pre-Tax Income | -$77,137 | -$238,710 | $34,770 | -$9,721 |
| Tax Expense | -$287 | -$19,000 | -$609 | $15,966 |
| Net Income | -$77,424 | -$219,710 | $35,379 | -$25,687 |
| % Margin | -199% | – | 31.9% | -30.2% |
| EPS | -0.5 | -1.42 | 0.24 | -0.22 |
| % Growth | 64.8% | -691.7% | 209.1% | – |
| EPS Diluted | -0.5 | -1.42 | 0.24 | -0.22 |
| Weighted Avg Shares Out | 155,110 | 154,957 | 144,759 | 114,329 |
| Weighted Avg Shares Out Dil | 155,110 | 154,957 | 145,875 | 114,329 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7,386 | $0 | $958 | $2,800 |
| Interest Expense | $0 | -$2,833 | $3,031 | $2,844 |
| Depreciation & Amortization | $0 | $764 | $1,617 | $15 |
| EBITDA | $0 | -$240,779 | $16,155 | -$6,862 |
| % Margin | 0% | – | 14.6% | -8.1% |